Biovica will attend the ASCO Annual Meeting, an event that brings together 30 000 oncology professionals from around the world. Biovica aims to expand the collaboration and research network and to share the latest insights from on going clinical trials.
“At ASCO we look forward to meet our academic partners and to expand our collaborations with oncologists and pharmaceutical companies. Our ambition is to provide our partners access to the DiviTum™ technology to predict and evaluate drug efficacy for new cancer drugs so that patients can get the best possible treatment.” – Mattias Bergqvist, VP Marketing & Clinical Studies
MEET US AT THE ASCO ANNUAL MEETING
Contact us at bd@biovica.com
Follow Biovica